Bernard Le Foll

Translational Addiction Research Laboratory

The main goal of the Translational Addiction Research Laboratory is to improve the treatment and understanding of drug addiction. The research aims at linking discovery in basic science to clinical applications. The research program is currently covering various drugs of abuse (cannabis, opioid, tobacco and alcohol). The main approaches used in the laboratory are i) PET imaging approaches to uncover some of the neurotransmitters involved in drug addiction processes; ii) drug administration studies in the laboratory; iii) Randomized clinical trials.

Alcohol Research and Treatment Clinic

As part of the Concurrent Outpatient Medical & Psychosocial Addiction Support Service of CAMH ,  the Alcohol Research and Treatment Clinic (ARTC) brings together an inter-professional team of physicians, nurses and specialized therapists to improve access to pharmacotherapies for the treatment of alcohol dependence. Led by Dr. Bernard Le Foll, the clinic also includes research and evaluation components to find new evidence-based treatment strategies that will inform delivery of care at CAMH, throughout the province and beyond. ARTC is currently using approved pharmacotherapies (disulfiram, naltrexone and acamprosate) and second lines therapies (gabapentin, topiramate and baclofen).

Affiliations

Professor in the Departments of Psychiatry, Pharmacology and Toxicology, Family and Community Medicine, Institute of Medical Science and Dalla Lana School of Public Health

Head, Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH)

Lead, Clinical Research Innovation Service, Addiction Division, CAMH

Head, Alcohol Research and Treatment Clinic, CAMH.

Staff Physician, Centre for Addiction and Mental Health

Other Links

Click here to see our recent peer-reviewed publications:

http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=le+foll+b

Research Synopsis

Drug dependence; Clinical trials; Alcohol, nicotine and cannabis dependence; Preclinical models of drug dependence; Brain imaging; Genetic studies.